These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25793507)
1. Protein-binding RNA aptamers affect molecular interactions distantly from their binding sites. Dupont DM; Thuesen CK; Bøtkjær KA; Behrens MA; Dam K; Sørensen HP; Pedersen JS; Ploug M; Jensen JK; Andreasen PA PLoS One; 2015; 10(3):e0119207. PubMed ID: 25793507 [TBL] [Abstract][Full Text] [Related]
2. Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism. Botkjaer KA; Deryugina EI; Dupont DM; Gårdsvoll H; Bekes EM; Thuesen CK; Chen Z; Ploug M; Quigley JP; Andreasen PA Mol Cancer Res; 2012 Dec; 10(12):1532-43. PubMed ID: 23038812 [TBL] [Abstract][Full Text] [Related]
4. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis. Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782 [TBL] [Abstract][Full Text] [Related]
5. Activation of the zymogen to urokinase-type plasminogen activator is associated with increased interdomain flexibility. Behrens MA; Botkjaer KA; Goswami S; Oliveira CL; Jensen JK; Schar CR; Declerck PJ; Peterson CB; Andreasen PA; Pedersen JS J Mol Biol; 2011 Aug; 411(2):417-29. PubMed ID: 21669207 [TBL] [Abstract][Full Text] [Related]
6. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers. Damare J; Brandal S; Fortenberry YM Nucleic Acid Ther; 2014 Aug; 24(4):239-49. PubMed ID: 24922319 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA. Dreymann N; Wuensche J; Sabrowski W; Moeller A; Czepluch D; Vu Van D; Fuessel S; Menger MM Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563278 [TBL] [Abstract][Full Text] [Related]
13. Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor. Nagase K; Kobayashi H; Yoshikawa E; Kurita N J Mol Graph Model; 2009 Aug; 28(1):46-53. PubMed ID: 19403319 [TBL] [Abstract][Full Text] [Related]
14. Building a Molecular Trap for a Serine Protease from Aptamer and Peptide Modules. Dupont DM; Bjerregaard N; Verpaalen B; Andreasen PA; Jensen JK Bioconjug Chem; 2016 Apr; 27(4):918-26. PubMed ID: 26926041 [TBL] [Abstract][Full Text] [Related]
16. Electroanalysis of pM-levels of urokinase plasminogen activator in serum by phosphorothioated RNA aptamer. Jarczewska M; Kékedy-Nagy L; Nielsen JS; Campos R; Kjems J; Malinowska E; Ferapontova EE Analyst; 2015 Jun; 140(11):3794-802. PubMed ID: 25620243 [TBL] [Abstract][Full Text] [Related]
17. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen. Boutaud A; Castellino FJ Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311 [TBL] [Abstract][Full Text] [Related]
18. Facile characterization of aptamer kinetic and equilibrium binding properties using surface plasmon resonance. Chang AL; McKeague M; Smolke CD Methods Enzymol; 2014; 549():451-66. PubMed ID: 25432760 [TBL] [Abstract][Full Text] [Related]
19. The effects of amino-acid mutations on specific interactions between urokinase-type plasminogen activator and its receptor: Ab initio molecular orbital calculations. Tsuji S; Kasumi T; Nagase K; Yoshikawa E; Kobayashi H; Kurita N J Mol Graph Model; 2011 Aug; 29(8):975-84. PubMed ID: 21605990 [TBL] [Abstract][Full Text] [Related]
20. Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis. Fortenberry YM; Brandal SM; Carpentier G; Hemani M; Pathak AP PLoS One; 2016; 11(10):e0164288. PubMed ID: 27755560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]